Healthequity Inc (NASDAQ:HQY) insider Berkley Capital, Llc sold 100,000 shares of the firm’s stock in a transaction that occurred on Thursday, February 8th. The stock was sold at an average price of $51.25, for a total transaction of $5,125,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Berkley Capital, Llc also recently made the following trade(s):

  • On Monday, February 12th, Berkley Capital, Llc sold 350,000 shares of Healthequity stock. The stock was sold at an average price of $52.12, for a total transaction of $18,242,000.00.
  • On Wednesday, November 29th, Berkley Capital, Llc sold 700 shares of Healthequity stock. The stock was sold at an average price of $52.05, for a total transaction of $36,435.00.
  • On Monday, November 27th, Berkley Capital, Llc sold 12,300 shares of Healthequity stock. The stock was sold at an average price of $52.14, for a total transaction of $641,322.00.
  • On Wednesday, November 22nd, Berkley Capital, Llc sold 11,200 shares of Healthequity stock. The stock was sold at an average price of $51.54, for a total transaction of $577,248.00.
  • On Friday, November 24th, Berkley Capital, Llc sold 77,221 shares of Healthequity stock. The stock was sold at an average price of $51.31, for a total transaction of $3,962,209.51.
  • On Thursday, November 16th, Berkley Capital, Llc sold 23,479 shares of Healthequity stock. The stock was sold at an average price of $51.08, for a total transaction of $1,199,307.32.

Healthequity Inc (NASDAQ HQY) traded up $1.36 during midday trading on Monday, reaching $52.65. 979,509 shares of the company traded hands, compared to its average volume of 475,368. Healthequity Inc has a 52-week low of $37.62 and a 52-week high of $55.31. The stock has a market capitalization of $3,190.00, a price-to-earnings ratio of 71.15, a price-to-earnings-growth ratio of 1.96 and a beta of 1.70.

Healthequity (NASDAQ:HQY) last posted its quarterly earnings results on Tuesday, December 5th. The company reported $0.17 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.13 by $0.04. Healthequity had a net margin of 21.08% and a return on equity of 14.47%. The firm had revenue of $56.80 million for the quarter, compared to analyst estimates of $55.27 million. During the same quarter last year, the firm posted $0.10 earnings per share. Healthequity’s revenue for the quarter was up 31.0% compared to the same quarter last year. equities analysts expect that Healthequity Inc will post 0.73 EPS for the current year.

Several research firms recently issued reports on HQY. Zacks Investment Research raised shares of Healthequity from a “hold” rating to a “buy” rating and set a $57.00 target price on the stock in a research report on Saturday. Cantor Fitzgerald raised their target price on shares of Healthequity from $56.00 to $60.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 7th. Robert W. Baird raised their target price on shares of Healthequity from $48.00 to $49.00 and gave the stock a “neutral” rating in a research report on Wednesday, February 7th. JPMorgan Chase & Co. decreased their target price on shares of Healthequity from $52.00 to $51.00 and set an “overweight” rating on the stock in a research report on Wednesday, January 24th. Finally, BidaskClub raised shares of Healthequity from a “sell” rating to a “hold” rating in a research report on Tuesday, November 7th. Two analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus price target of $56.67.

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Ameritas Investment Partners Inc. raised its holdings in Healthequity by 17.4% in the second quarter. Ameritas Investment Partners Inc. now owns 4,375 shares of the company’s stock valued at $218,000 after buying an additional 648 shares during the period. Advisory Services Network LLC raised its holdings in Healthequity by 4.1% in the fourth quarter. Advisory Services Network LLC now owns 31,425 shares of the company’s stock valued at $1,466,000 after buying an additional 1,230 shares during the period. Stifel Financial Corp raised its holdings in Healthequity by 3.4% in the second quarter. Stifel Financial Corp now owns 38,873 shares of the company’s stock valued at $1,916,000 after buying an additional 1,263 shares during the period. UBS Asset Management Americas Inc. raised its holdings in Healthequity by 4.3% in the fourth quarter. UBS Asset Management Americas Inc. now owns 32,586 shares of the company’s stock valued at $1,520,000 after buying an additional 1,348 shares during the period. Finally, Louisiana State Employees Retirement System raised its stake in shares of Healthequity by 6.8% during the fourth quarter. Louisiana State Employees Retirement System now owns 22,100 shares of the company’s stock valued at $1,031,000 after purchasing an additional 1,400 shares during the period. Hedge funds and other institutional investors own 98.63% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Healthequity Inc (HQY) Insider Berkley Capital, Llc Sells 100,000 Shares” was originally posted by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are viewing this piece of content on another website, it was stolen and republished in violation of U.S. and international trademark and copyright law. The original version of this piece of content can be viewed at https://theolympiareport.com/2018/02/12/healthequity-inc-hqy-insider-berkley-capital-llc-sells-100000-shares.html.

About Healthequity

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Insider Buying and Selling by Quarter for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.